DNA Polymerase Alpha Subunit B Is a Binding Protein for Erlotinib Resistance in Non-Small Cell Lung Cancer

SIMPLE SUMMARY: Non-small-cell lung carcinoma (NSCLC) covers for almost 85% of all lung cancers and a major contributor to the overall cancer death rate. Erlotinib is used to treat NSCLC via inhibition of epithelial growth factor receptor (EGFR) kinase activity. Despite its high efficacy, recurrence...

Descripción completa

Detalles Bibliográficos
Autores principales: Kim, Tae Young, Ji, Eun Sun, Lee, Ju Yeon, Kim, Jin Young, Yoo, Jong Shin, Szasz, A. Marcell, Dome, Balazs, Marko-Varga, Gyorgy, Kwon, Ho Jeong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7564424/
https://www.ncbi.nlm.nih.gov/pubmed/32933200
http://dx.doi.org/10.3390/cancers12092613

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7564424/
https://www.ncbi.nlm.nih.gov/pubmed/32933200
http://dx.doi.org/10.3390/cancers12092613

Ejemplares similares